BridgeMD
New treatment option for Miscarriage in First Trimester
Official title GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA
ClinicalTrials.gov ID: NCT07639333
What this study is testing
What is Non invasive prenatal test?
Non invasive prenatal test is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for miscarriage in first trimester.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 43, women only
You may be able to join if
- A stopped pregnancy with an intrauterine pregnancy diagnosed by ultrasound (embryo larger than 7 mm corresponding to a gestational age of 6 weeks and...
- Expulsion of a pregnancy within the last 2 hours
- Patient fluent in French
- Enrolled in a social security program
- Has received oral and written information about the protocol and has signed a consent form to participate in this research.
You likely can't join if
- Diagnosis of an empty gestational sac, ectopic pregnancy, or unknown location
- Ultrasound findings consistent with a molar pregnancy
- Identified cause (preimplantation diagnosis, multiple uterine fibroids or a single fibroid \> 5 cm, uterine malformation affecting the uterine...
- Inability to obtain a blood sample
- Known current malignant tumor
- Blood transfusions within the last 3 months
See the full eligibility criteria
- A stopped pregnancy with an intrauterine pregnancy diagnosed by ultrasound (embryo larger than 7 mm corresponding to a gestational age of 6 weeks and 5 days. This is justified by the fact that fetal fragment (FF)...
- Expulsion of a pregnancy within the last 2 hours
- Patient fluent in French
- Enrolled in a social security program
- Has received oral and written information about the protocol and has signed a consent form to participate in this research.
- Diagnosis of an empty gestational sac, ectopic pregnancy, or unknown location
- Ultrasound findings consistent with a molar pregnancy
- Identified cause (preimplantation diagnosis, multiple uterine fibroids or a single fibroid \> 5 cm, uterine malformation affecting the uterine cavity, lupus, and antiphospholipid syndrome)
- Inability to obtain a blood sample
- Known current malignant tumor
- Blood transfusions within the last 3 months
- Cell therapy or immunotherapy within the last 3 months
- Previous organ transplant
The study team makes the final eligibility decision.
Where it's taking place
- Rennes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 43 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rennes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.